Akèy › Kansè Poumon ki pa ti selil › New York › Greenburgh
Etid klinik pou Kansè Poumon ki pa ti selil nan Greenburgh, NY
28 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Greenburgh (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ap rekriteFaz 3
- Phelps Memorial Hospital Center, Sleepy Hollow · 4 mi lwen
- Dickstein Cancer Treatment Center, White Plains · 4 mi lwen
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Ap rekriteFaz 2
- Memorial Sloan Kettering Bergen, Montvale · 9 mi lwen
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Ap rekriteFaz 3
- Westchester Medical Center ( Site 0196), Valhalla · 5 mi lwen
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Ap rekriteFaz 2/3
- White Plains Hospital, White Plains · 4 mi lwen
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Ap rekriteFaz 3
- White Plains Hospital ( Site 3213), White Plains · 4 mi lwen
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Ap rekriteFaz 3
- White Plains Hospital, White Plains · 4 mi lwen
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Ap rekriteFaz 3
- White Plains Hospital ( Site 0091), White Plains · 4 mi lwen
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Hematology Oncology Associates of Rockland, Nyack · 6 mi lwen
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Ap rekriteFaz 3
- Hematology Oncology Associates of Rockland, Nyack · 6 mi lwen
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Ap rekriteFaz 3
- White Plains Hospital, White Plains · 4 mi lwen
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Ap rekriteFaz 2/3
- White Plains Hospital, White Plains · 4 mi lwen
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
Ap rekriteFaz 1
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi lwen
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Ap rekriteFaz 2
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), East White Plains · 5 mi lwen
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi lwen
Using Urine Samples to Identify Lung Cancer
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi lwen
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
Ap rekriteFaz 2
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi lwen
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Ap rekrite
- Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale · 9 mi lwen
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Ap rekriteFaz 3
- Memorial Sloan Kettering Bergen, Montvale · 9 mi lwen
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
Ap rekriteFaz 2
- Memorial Sloan Kettering Bergen, Montvale · 9 mi lwen
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi lwen
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering Bergen (Consent Only), Montvale · 9 mi lwen
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi lwen
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
Ap rekriteFaz 2
- Memorial Sloan Kettering Bergen (All protocol activities), Montvale · 9 mi lwen
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Memorial Sloan Kettering Bergen, Montvale · 9 mi lwen
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi lwen
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi lwen
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Ap rekriteFaz 2
- Memorial Sloan Kettering Bergen, Montvale · 9 mi lwen
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi lwen
GEMINI-NSCLC: NSCLC Biomarker Study
Ap rekriteEtid obsèvasyon
- White Plains Hospital, White Plains · 4 mi lwen
Etid Kansè Poumon ki pa ti selil nan lòt vil
- Houston, TX145 etid
- New York City, NY121 etid
- Arlington, VA104 etid
- Nashville, TN97 etid
- Boston, MA90 etid
- Los Angeles, CA87 etid
- St. Louis, MO73 etid
- Chicago, IL61 etid
- Baltimore, MD60 etid
- San Antonio, TX59 etid
- Columbus, OH57 etid
- Washington, DC55 etid
Lòt etid nan Greenburgh
- Kansè nan tete42 etid
- Leksemi mieloïd egi18 etid
- Kansè pwostat17 etid
- Kansè (tout kalite)17 etid
- Kansè poumon17 etid
- Myelom Miltip13 etid
- Kansè kolorektal11 etid
- Kansè Metastatik11 etid
- Kansè Endomèt11 etid
- Kansè vejik10 etid
- Limfom9 etid
- Karsinòm selil skuamèz tèt ak kou9 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.